MetAP2

Shares of Zafgen Inc (NASDAQ: ZFGN), a biopharmaceutical company that develops therapies for patients affected by obesity and complex metabolic disorders, were trading higher by nearly 40 percent at $7.80 early Wednesday morning. Zafgen announced after Tuesday's market positive efficacy...